4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses - PubMed (original) (raw)
. 1999 Nov 1;163(9):4859-68.
Affiliations
- PMID: 10528187
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
J T Tan et al. J Immunol. 1999.
Abstract
4-1BB (CD137) is a costimulatory molecule expressed on activated T cells and interacts with 4-1BB ligand (4-1BBL) on APCs. To investigate the role of 4-1BB costimulation for the development of primary immune responses, 4-1BBL-deficient (4-1BBL-/-) mice were infected with lymphocytic choriomeningitis virus (LCMV). 4-1BBL-/- mice were able to generate CTL and eliminate acute LCMV infection with normal kinetics, but CD8 T cell expansion was 2- to 3-fold lower than in wild-type (+/+) mice. In the same mice, virus-specific CD4 Th and B cell responses were minimally affected, indicating that 4-1BB costimulation preferentially affects CD8 T cell responses. This result contrasts with our earlier work with CD40L-deficient (CD40L-/-) mice, in which the CD8 T cell response was unaffected and the CD4 T cell response was markedly impaired. When both 4-1BBL- and B7-dependent signals were absent, CD8 T cell expansion was further reduced, resulting in lower CTL activity and impairing their ability to clear LCMV. Altogether, these results indicate that T cells have distinct costimulatory requirements: optimal CD8 responses require 4-1BBL-dependent interactions, whereas CD4 responses are minimally affected by 4-1BB costimulation, but require CD40-CD40L and B7-dependent interactions.
Similar articles
- CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. Whitmire JK, et al. J Immunol. 1999 Sep 15;163(6):3194-201. J Immunol. 1999. PMID: 10477587 - Costimulation of CD28- T lymphocytes by 4-1BB ligand.
DeBenedette MA, Shahinian A, Mak TW, Watts TH. DeBenedette MA, et al. J Immunol. 1997 Jan 15;158(2):551-9. J Immunol. 1997. PMID: 8992967 - Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT, Mufti GJ, Guinn BA. Cheuk AT, et al. Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670. Cancer Gene Ther. 2004. PMID: 14671675 Review. - Role of 4-1BB in immune responses.
Vinay DS, Kwon BS. Vinay DS, et al. Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157. Semin Immunol. 1998. PMID: 9826581 Review.
Cited by
- 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.
Lee DY, Choi BK, Lee DG, Kim YH, Kim CH, Lee SJ, Kwon BS. Lee DY, et al. PLoS One. 2013 Jul 11;8(7):e69677. doi: 10.1371/journal.pone.0069677. Print 2013. PLoS One. 2013. PMID: 23874982 Free PMC article. - Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.
Salek-Ardakani S, Croft M. Salek-Ardakani S, et al. J Interferon Cytokine Res. 2010 Apr;30(4):205-18. doi: 10.1089/jir.2010.0026. J Interferon Cytokine Res. 2010. PMID: 20377415 Free PMC article. Review. - CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand.
Fuse S, Bellfy S, Yagita H, Usherwood EJ. Fuse S, et al. J Immunol. 2007 Apr 15;178(8):5227-36. doi: 10.4049/jimmunol.178.8.5227. J Immunol. 2007. PMID: 17404306 Free PMC article. - Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells.
Mogi S, Sakurai J, Kohsaka T, Enomoto S, Yagita H, Okumura K, Azuma M. Mogi S, et al. Immunology. 2000 Dec;101(4):541-7. doi: 10.1046/j.1365-2567.2000.t01-1-00138.x. Immunology. 2000. PMID: 11122458 Free PMC article. - Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.
Dadas O, Ertay A, Cragg MS. Dadas O, et al. Front Immunol. 2023 Apr 25;14:1147467. doi: 10.3389/fimmu.2023.1147467. eCollection 2023. Front Immunol. 2023. PMID: 37180119 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous